Overexpression of AXL in colorectal tumors was reported in metastatic lesions [24] and AXL was recently characterized as a poor prognostic marker in early stage colorectal tumors, and as an important mediator of basal and 5-FU induced EMT and invasiveness [25]. The gene discussed is AXL; the disease is colorectal neoplasm.